Triple
T18213149
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | vincristine |
E436082
|
entity |
| Predicate | usedInRegimen |
P25490
|
FINISHED |
| Object | CHOP chemotherapy regimen |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CHOP chemotherapy regimen | Statement: [vincristine, usedInRegimen, CHOP chemotherapy regimen]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CHOP chemotherapy regimen Context triple: [vincristine, usedInRegimen, CHOP chemotherapy regimen]
-
A.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
B.
R-CHOP
chosen
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
C.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
D.
FOLFIRI regimen
The FOLFIRI regimen is a combination chemotherapy protocol, typically including folinic acid, fluorouracil, and irinotecan, commonly used to treat advanced colorectal cancer.
-
E.
cyclophosphamide
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: usedInRegimen Context triple: [vincristine, usedInRegimen, CHOP chemotherapy regimen]
-
A.
usesDrug
Indicates that an entity consumes, administers, or otherwise makes use of a specified drug.
-
B.
areUsedIn
chosen
Indicates that certain entities serve as components, tools, or resources within a particular process, context, or application.
-
C.
hasDosingRegimen
Indicates that an entity is associated with a specific dosing regimen, defining how and when a dose is to be administered.
-
D.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
E.
usesTreatment
Indicates that one entity applies or employs a particular treatment or therapeutic method on or for another entity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b90dba6481908e119eb9aa4ca0cb |
completed | April 10, 2026, 8:47 a.m. |
| NER | Named-entity recognition | batch_69e4e22a26308190a6720b41a9bbfc2d |
completed | April 19, 2026, 2:09 p.m. |
| PD | Predicate disambiguation | batch_69e4332155d88190b106d0dceb4554af |
completed | April 19, 2026, 1:42 a.m. |
Created at: April 10, 2026, 10:32 a.m.